Dechra Pharmaceuticals Ltd. is a holding company, which engages in the veterinary pharmaceuticals and related products business. It operates through the following segments: European Pharmaceuticals; North American Pharmaceuticals; and Pharmaceuticals Research and Development. The European Pharmaceuticals segment markets and sells licensed pharmaceuticals and specialist pet foods to the veterinary profession in Europe. The North American Pharmaceuticals segment focuses on the sale of a range of endocrine, ophthalmic, dermatological, and equine products in North America. The Pharmaceuticals Research and Development segment develops and licenses Dechra's own branded veterinary product portfolio of novel and generic pharmaceuticals and specialist pet diets. The company was founded in 1819 and is headquartered in Northwich, the United Kingdom.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Dechra Pharmaceuticals plc market cap is $5.34B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Dechra Pharmaceuticals plc 52 week high is $47.40 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Dechra Pharmaceuticals plc 52 week low is $30.00 as of November 18, 2026.
Dechra Pharmaceuticals plc stock price today is $46.90.
Dechra Pharmaceuticals plc stock price yesterday was $47.00.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Dechra Pharmaceuticals plc's P/E ratio is -148.89.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Dechra Pharmaceuticals plc P/B ratio is 5.5632.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Dechra Pharmaceuticals plc 50-day moving average is $46.91.